Warning: mkdir(): Permission denied in /home/virtual/lib/view_data.php on line 81

Warning: fopen(upload/ip_log/ip_log_2024-07.txt): failed to open stream: No such file or directory in /home/virtual/lib/view_data.php on line 83

Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 84
Association between Physical Activity and Hypertension in Chronic Obstructive Pulmonary Disease

Korean J Health Promot > Volume 16(2); 2016 > Article
Jang, Ryu, Kim, Lee, and Jung: Association between Physical Activity and Hypertension in Chronic Obstructive Pulmonary Disease

요약

Background

Patients with chronic obstructive pulmonary disease (COPD) have increased likelihood of hypertension, which may lead to increased mortality rates. This study investigated the incidence of hypertension in patients with COPD according to the levels of their physical activities.

Methods

This study used data from the fifth Korean National Health and Nutrition Examination Survey, conducted from 2010 to 2012, including 1,243 people aged 40 years or older with COPD who were cross-classified according to their levels of physical activity. The relevance of morbidity associated with high blood pressure was also evaluated through cross and logistic regression analyses.

Results

Among patients with COPD who performed moderate-intensity physical activities, the group without hypertension had 4.3% higher compared to the group with hypertension (P=0.012). Adjusted analysis for patient age, sex, body mass index, smoking, drinking habit, income, diabetes mellitus, hyperlipidemia, and energy intake performed to determine the relationship between physical activity level and hypertension revealed that patients with moderate-intensity physical activity had 53.6% lower (95% confidence interval: 0.288–0.997) incidence of hypertension.

Conclusions

The results of the current study suggest that patients with COPD who perform moderate-intensity physical activity have a lower incidence of hypertension.

Table 1.
General Characteristics of subjects (unweighted n = 1,243)
Variable Non-hypertension (n = 593) Hypertension (n = 650) P
Male sex 74.1 (2.4) 75.4 (2.3) 0.673a
Current smoking 64.4 (2.6) 72 (2.3) 0.028a
Heavy drinker 13.8 (2) 11.7 (1.7) 0.40a
Income 25.7 (2.2) 32.3 (2.2) 0.024a
Education 57.3 (2.7) 61.6 (2.5) 0.221a
Marriage status (yes) 88.7 (1.6) 77.5 (2.2) <0.001a
DM (yes) 12.2 (1.6) 20.6 (2.1) 0.002a
Hyperlipidemia (yes) 10 (1.6) 21.4 (2) <0.001a
Chronic bronchitis or emphysema (yes) 2.4 (0.7) 2.5 (0.8) 0.916a
Age, y 59.7±0.5 64.9±0.5 <0.001b
BMI, kg/m2 23.3±0.1 24.1±0.2 <0.001b
WC, cm 83.2±0.5 86.1±0.4 <0.001b
SBP, mmHg 116.9±0.6 136.2±0.9 <0.001b
DBP, mmHg 73.9±0.5 81.7±0.6 <0.001b
FVC, L 3.8±0.1 3.5±0.1 <0.001b
FEV1, L 2.4±0.0 2.3±0.0 <0.001b
FEV1/FVC 0.635±0.004 0.634±0.003 0.742b
Energy intake, kcal 2235.4±60.2 1928.5±40.4 <0.001b

Abbreviations: SE, standard error; DM, diabetes mellitus; BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second. Values are presented as percentage (SE) or mean±SE.

a Calculated by chi-square test.

b Calculated by t-test.

Table 2.
Association between physical activity and hypertension in COPD patients
  Physical activity
  Vigorous (yes) (n = 154) Moderate (yes) (n = 92) Mild (yes) (n = 488)
Non-hypertension 13 (1.9) 9.2 (1.5) 38.2 (2.7)
Hypertension 11 (1.5) 4.9 (1) 39.5 (2.3)
Pa 0.390 0.012 0.709

Abbreviations: COPD, chronic obstructive pulmonary disease. Values are presented as percentage (SE).

a Calculated by chi-square test.

Table 3.
Correlations between hypertension and intensity of physical activity in COPD patientsa
  Physical activity
  Vigorous (yes) (n = 154) Moderate (yes) (n = 92) Mild (yes) (n = 488)
Model 1b 0.830a (0.542–1.270) 0.511a (0.299–0.871) 1.060a (0.782–1.435)
Model 2c 0.962a (0.607–1.526) 0.528a (0.298–0.938) 0.992a (0.724–1.359)
Model 3d 0.789a (0.497–1.252) 0.536a (0.288–0.997) 0.951a (0.668–1.356)

Abbreviations: COPD, chronic obstructive pulmonary disease; BMI, body mass index; DM, diabetes mellitus. Reference was hypertensive group in COPD patients. Calculated by multiple logistic regression analysis. Model 1: not adjusted. Model 2: adjusted for age, sex, BMI, smoking, and drinking. Model 3: adjusted for age, sex, BMI, smoking, drinking, income, DM, hyperlipidemia, and energy intake.

References

1. Moon HS. Guideline of COPD. Reston: Korean Academy of Tuberculosis and Respiratory Diseases; 2012. [Accessed July 15, 2015].. http://www.lungkorea.org/thesis/guide.php.
2. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006;27(2):397-412.
crossref pmid
3. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3(11):): e442..
crossref
4. Bousquet J, Kiley J, Bateman ED, Viegi G, Cruz AA, Khaltaev N, et al. Prioritised research agenda for prevention and control of chronic respiratory diseases. Eur Respir J 2010;36(5):995-1001.
crossref pmid
5. Yoo KH, Kim YS, Sheen SS, Park JH, Hwang YI, Kim SH, et al. Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and Nutrition Examination Survey, 2008. Respirology 2011;16(4):659-65.
crossref pmid
6. Maclay JD, McAllister DA, Macnee W. Cardiovascular risk in chronic obstructive pulmonary disease. Respirology 2007;12(5):): 634 –41..
crossref
7. Korea Centers for Disease Control and Prevention. The Third Korea National health statistics National Health and Nutrition Examination Survey (KNHANS IV). Seoul: Korea Centers for Disease Control and Prevention; 2011. p. 1-727.
8. World Health Organization. A global brief on Hypertension. Geneva: World Health Organization; 2013. [Accessed August 1, 2015].. http://www.who.int/cardiovascular_diseases/publications/global_brief_hypertension.pdf.
9. Padwal R, Straus SE, McAlister FA. Evidence based management of hypertension. Cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based review. BMJ 2001;322(7292):977-80.
crossref pmid pmc
10. Antonelli-Incalzi R, Fuso L, De Rosa M, Forastiere F, Rapiti E, Nardecchia B, et al. Comorbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997;10(12):2794-800.
crossref pmid
11. Jo YS, Choi SM, Lee J, Park YS, Lee SM, Yim JJ, el al. The relationship between chronic obstructive pulmonary disease and comorbidities: a cross-sectional study using data from KNH-ANES 2010–2012. Respir Med 2015;109(1):96-104.
crossref pmid
12. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008;32(4):962-9.
crossref pmid
13. Bento VF, Albino FB, Moura KF, Maftum GJ, Santos Mde C, Guarita-Souza LC, et al. Impact of physical activity interventions on blood pressure in Brazilian populations. Arq Bras Cardiol 2015;105(3):301-8.
crossref pmid pmc
14. Fagard RH. Exercise characteristics and the blood pressure response to dynamic physical training. Med Sci Sports Exerc 2001;33(6 Suppl):): S484–92; discussion. S493-4.
crossref
15. Padillla J, Wallace JP, Park S. Accumulation of physical activity reduces blood pressure in pre- and hypertension. Med Sci Sports Exerc 2005;37(8):1264-75.
crossref pmid
16. IPAQ research committee. Guideline for data processing and analysis of the international physical activity questionnaire (IPAQ) – Short and long forms, Revised Nov 2005. Place unknown: IPAQ research committee;. 2010;[Accessed July 30, 2015].. https://sites.google.com/site/theipaq/scoring-protocol.
17. Finkelstein J, Cha E, Scharf SM. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int J Chron Obstruct Pulmon Dis 2009;4:337-49.
crossref pmid pmc
18. Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest 2005;128(4):2640-6.
crossref pmid


Editorial Office
Department of Family Medicine, Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea
Tel: +82-2-3010-3820   Fax: +82-2-3010-3815   E-mail: kshpdp@amc.seoul.kr                

Copyright © 2024 by Korean Society For Health Promotion And Disease Prevention.

Developed in M2PI